A landmark report on the global economic impact of dementia finds that Alzheimer's disease and other dementias are exacting a massive toll on the global economy, with the problem set to accelerate in coming years. The worldwide costs of dementia will exceed 1% of global Gross Domestic Product (GDP) in 2010, at $604 billion, and increase to $1,000 billion a year by 2030. Action is needed from governments around the world, the report urges.
The World Alzheimer Report 2010 - issued on World Alzheimer's Day by Alzheimer's Disease International (ADI) - provides the most current and comprehensive global picture of the economic and social costs of the illness. The Report was jointly authored by Anders Wimo of the Karolinska Institutet, Stockholm, Sweden; and Martin Prince, Institute of Psychiatry, King's College London, UK.
Most significant health crisis of 21st Century
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze